GE HealthCare Technologies Inc.GEHC
GE HealthCare Technologies Inc. Segments Disclosure
SEGMENT AND GEOGRAPHICAL INFORMATION
GE HealthCare’s operations are organized and managed through four reportable segments: Imaging, Advanced Visualization Solutions (“AVS”), Patient Care Solutions (“PCS”), and Pharmaceutical Diagnostics (“PDx”). These segments have been identified based on the nature of the products sold and how the Company manages its operations. We have not aggregated any of our operating segments to form reportable segments. A description of our reportable segments has been provided in Item 1, “Business” of this Annual Report on Form 10-K.
The Company’s organizational structure is based upon the availability of separate financial information that is evaluated regularly by the Company’s Chief Operating Decision Maker (“CODM”) for the purpose of assessing performance and allocating resources. The Company’s CODM is our Chief Executive Officer. The CODM assesses segment performance using Total revenues and an earnings metric defined as “Segment EBIT.” Segment EBIT is calculated as income before income taxes in our Consolidated Statements of Income excluding the impact of the following: Interest and other financial charges – net, Non-operating benefit (income) costs, restructuring costs, acquisition and disposition-related benefits (charges), gain (loss) on business and asset dispositions, Spin-Off and separation costs, amortization of acquisition-related intangible assets, and investment revaluation gain (loss). Segment EBIT is also used in the annual budget and periodic forecasting processes and informs the CODM in decision making regarding the allocation of resources to the segments.
| Total Revenues by Segment | For the years ended December 31 | ||||||||||
| 2025 | 2024 | 2023 | |||||||||
| Total Imaging | $ | 9,245 | $ | 8,855 | $ | 8,944 | |||||
AVS: | |||||||||||
| Procedural Guidance | 2,752 | 2,711 | 2,666 | ||||||||
| Specialized Ultrasound | 2,601 | 2,420 | 2,428 | ||||||||
Total AVS | 5,354 | 5,131 | 5,094 | ||||||||
| PCS: | |||||||||||
Monitoring Solutions | 2,256 | 2,194 | 2,283 | ||||||||
Life Support Solutions | 831 | 931 | 859 | ||||||||
| Total PCS | 3,086 | 3,125 | 3,142 | ||||||||
| Total PDx | 2,900 | 2,508 | 2,306 | ||||||||
Other(1) | 40 | 52 | 66 | ||||||||
| Total revenues | $ | 20,625 | $ | 19,672 | $ | 19,552 | |||||
(1) Financial information not presented within the reportable segments, shown within the Other category, represents HealthCare Financial Services (“HFS”) which does not meet the definition of an operating segment.
No single customer accounted for more than 10% of the Company’s revenues for the years ended December 31, 2025, 2024, or 2023. Additionally, no single customer accounted for more than 10% of accounts receivable as of December 31, 2025 or 2024.
| Significant Expenses by Segment | For the years ended December 31 | ||||||||||
| 2025 | 2024 | 2023 | |||||||||
| Imaging: | |||||||||||
| Cost of sales | $ | 6,099 | $ | 5,623 | $ | 5,901 | |||||
Other segment items(1) | 2,255 | 2,270 | 2,222 | ||||||||
| Total Imaging | $ | 8,353 | $ | 7,893 | $ | 8,123 | |||||
| AVS: | |||||||||||
| Cost of sales | $ | 2,629 | $ | 2,485 | $ | 2,485 | |||||
Other segment items(1) | 1,550 | 1,528 | 1,485 | ||||||||
| Total AVS | $ | 4,178 | $ | 4,014 | $ | 3,970 | |||||
| PCS: | |||||||||||
| Cost of sales | $ | 2,028 | $ | 1,930 | $ | 1,890 | |||||
Other segment items(1) | 849 | 848 | 869 | ||||||||
| Total PCS | $ | 2,877 | $ | 2,778 | $ | 2,759 | |||||
| PDx: | |||||||||||
| Cost of sales | $ | 1,450 | $ | 1,236 | $ | 1,192 | |||||
Other segment items(1) | 579 | 490 | 497 | ||||||||
| Total PDx | $ | 2,028 | $ | 1,725 | $ | 1,689 | |||||
(1) Other segment items for each segment includes selling, general, administrative, research, and development related expenses, as well as other segment income and expenses.
| Segment EBIT | For the years ended December 31 | ||||||||||
| 2025 | 2024 | 2023 | |||||||||
| Segment EBIT | |||||||||||
| Imaging | $ | 891 | $ | 962 | $ | 821 | |||||
AVS | 1,175 | 1,118 | 1,124 | ||||||||
| PCS | 209 | 347 | 383 | ||||||||
| PDx | 872 | 783 | 617 | ||||||||
Other(1) | 7 | 2 | 11 | ||||||||
| 3,155 | 3,211 | 2,956 | |||||||||
| Restructuring costs | (120) | (120) | (54) | ||||||||
Acquisition and disposition-related benefits (charges) | (39) | (3) | 15 | ||||||||
Gain (loss) on business and asset dispositions | 5 | — | — | ||||||||
| Spin-Off and separation costs | (38) | (251) | (270) | ||||||||
| Amortization of acquisition-related intangible assets | (156) | (137) | (127) | ||||||||
| Investment revaluation gain (loss) | 112 | (22) | 1 | ||||||||
| Interest and other financial charges – net | (440) | (504) | (542) | ||||||||
| Non-operating benefit income (costs) | 288 | 406 | 382 | ||||||||
Income before income taxes | $ | 2,768 | $ | 2,581 | $ | 2,361 | |||||
(1) Financial information not presented within the reportable segments, shown within the Other category, primarily represents HFS which does not meet the definition of an operating segment.
The following table represents the depreciation and amortization amounts reported within the Segment EBIT metric for our reportable segments. Depreciation and amortization expense related to shared property, plant, and equipment and intangibles, exclusive of acquisition-related intangible assets, has been fully allocated to our segments and those allocations are reflected in the amounts presented in the table below. These amounts are included within Cost of sales and Other segment items disclosed in the Significant Expenses by Segment table above.
Depreciation and Amortization by Segment | For the years ended December 31 | ||||||||||
| 2025 | 2024 | 2023 | |||||||||
| Imaging | $ | 227 | $ | 249 | $ | 274 | |||||
| AVS | 70 | 78 | 90 | ||||||||
| PCS | 53 | 55 | 69 | ||||||||
| PDx | 66 | 55 | 45 | ||||||||
The Company does not report total assets by segment as the Company’s CODM does not assess performance, make strategic decisions, or allocate resources based on assets.
GEOGRAPHIC INFORMATION.
Revenues are classified according to the country in which products and services are sold.
| Total Revenues by Country | For the years ended December 31 | ||||||||||
| 2025 | 2024 | 2023 | |||||||||
| United States | $ | 9,168 | $ | 8,617 | $ | 8,228 | |||||
| China | 2,031 | 2,135 | 2,560 | ||||||||
| All other countries | 9,427 | 8,919 | 8,764 | ||||||||
| Total revenues | $ | 20,625 | $ | 19,672 | $ | 19,552 | |||||
Long-lived assets represent Property, plant, and equipment – net and are classified according to the country where the asset is located.
Long-Lived Assets – Net by Country | As of | |||||||
| December 31, 2025 | December 31, 2024 | |||||||
| United States | $ | 962 | $ | 908 | ||||
| China | 439 | 392 | ||||||
| Norway | 368 | 296 | ||||||
Japan | 296 | 62 | ||||||
All other countries | 1,027 | 893 | ||||||
Total long-lived assets – net | $ | 3,092 | $ | 2,550 | ||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 4, 2026 | Showing above |
| 2024 | Feb 13, 2025 | |
| 2023 | Feb 6, 2024 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.